Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Investment in real estate:    
Land $ 168,289 $ 152,060
Building 1,079,380 985,091
Site improvements 21,983 19,021
Tenant improvements 65,004 58,900
Acquired lease intangible assets 147,836 127,931
Investment in real estate, Total 1,482,492 1,343,003
Less: accumulated depreciation and amortization (182,255) (143,255)
Investment in real estate, net 1,300,237 1,199,748
Cash and cash equivalents 3,199 7,213
Restricted cash 10,396 5,546
Tenant receivables, net 6,382 6,070
Due from related parties 337 163
Escrow deposits 7,660 5,957
Deferred assets 28,667 25,417
Derivative asset 36,926 1,236
Goodwill 5,903 5,903
Other assets 7,042 6,232
Total assets 1,406,749 1,263,485
Liabilities:    
Credit Facility, net of unamortized debt issuance costs of $9,802 and $8,033 at September 30, 2022 and December 31, 2021, respectively 634,898 514,567
Notes payable, net of unamortized debt issuance costs of $491 and $607 at September 30, 2022 and December 31, 2021, respectively 57,918 57,162
Accounts payable and accrued expenses 13,100 10,344
Dividends payable 15,777 15,668
Security deposits 5,404 4,540
Derivative liability   7,790
Other liabilities 6,848 7,709
Acquired lease intangible liability, net 8,220 8,128
Total liabilities 742,165 625,908
Equity:    
Preferred stock, $0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at September 30, 2022 and December 31, 2021, respectively (liquidation preference of $77,625 at September 30, 2022 and December 31, 2021, respectively) 74,959 74,959
Common stock, $0.001 par value, 500,000 shares authorized; 65,518 shares and 64,880 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 66 65
Additional paid-in capital 722,074 711,414
Accumulated deficit (185,316) (157,017)
Accumulated other comprehensive income (loss) 36,883 (6,636)
Total Global Medical REIT Inc. stockholders' equity 648,666 622,785
Noncontrolling interest 15,918 14,792
Total equity 664,584 637,577
Total liabilities and equity $ 1,406,749 $ 1,263,485